|
ALKBH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.072200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.24659999995092E-06 |
| Normal-vs-Stage2 |
2.934600E-01 |
| Normal-vs-Stage3 |
2.673400E-01 |
| Normal-vs-Stage4 |
9.063400E-01 |
| Stage1-vs-Stage2 |
1.698560E-01 |
| Stage1-vs-Stage3 |
4.6305999999996E-06 |
| Stage1-vs-Stage4 |
2.113000E-01 |
| Stage2-vs-Stage3 |
8.840400E-02 |
| Stage2-vs-Stage4 |
6.558200E-01 |
| Stage3-vs-Stage4 |
6.008800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.350000E-02 |
| Normal-vs-AfricanAmerican |
1.121420E-01 |
| Normal-vs-Asian |
2.102200E-01 |
| Caucasian-vs-AfricanAmerican |
6.276800E-01 |
| Caucasian-vs-Asian |
5.207000E-01 |
| AfricanAmerican-vs-Asian |
5.518400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.674210E-01 |
| Normal-vs-Female |
3.402000E-03 |
| Male-vs-Female |
1.940180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.797200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.978600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.211800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.989800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.109230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.733400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.095000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.664460E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.614760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.040800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.53056999999679E-05 |
| Normal-vs-Grade 2 |
1.53272999999787E-05 |
| Normal-vs-Grade 3 |
9.616200E-01 |
| Normal-vs-Grade 4 |
5.279000E-01 |
| Grade 1-vs-Grade 2 |
4.24009999999697E-05 |
| Grade 1-vs-Grade 3 |
4.33429999668888E-08 |
| Grade 1-vs-Grade 4 |
2.00619999999319E-05 |
| Grade 2-vs-Grade 3 |
8.2668000000008E-05 |
| Grade 2-vs-Grade 4 |
6.336500E-02 |
| Grade 3-vs-Grade 4 |
5.229000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.58760002314062E-09 |
| Normal-vs-ccB subtype |
9.184300E-02 |
| ccA subtype-vs-ccB subtype |
3.86289888965052E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.986000E-02 |
| Normal-vs-N1 |
1.623300E-03 |
| N0-vs-N1 |
1.191740E-04 |
|
|
